Jeffrey Garro
Stock Analyst at Stephens
(0.07)
# 4,536
Out of 4,579 analysts
73
Total ratings
31.3%
Success rate
-23.7%
Average return
Main Sectors:
Stocks Rated by Jeffrey Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPRX OptimizeRx | Rated: Hold | $10 → $7 | $6.38 | +9.72% | 6 | May 13, 2026 | |
| HCAT Health Catalyst | Maintained: Hold | $2 → $1.75 | $2.15 | -18.60% | 5 | May 12, 2026 | |
| CERT Certara | Maintained: Buy | $12 → $9 | $7.75 | +16.13% | 6 | May 12, 2026 | |
| PHR Phreesia | Maintained: Buy | $37 → $20 | $10.63 | +88.15% | 3 | Mar 31, 2026 | |
| DH Definitive Healthcare | Maintained: Hold | $5 → $3 | $0.6736 | +345.37% | 2 | Feb 27, 2026 | |
| EVH Evolent Health | Maintained: Buy | $7 | $3.81 | +83.73% | 4 | Feb 25, 2026 | |
| SLP Simulations Plus | Maintained: Buy | $28 → $20 | $18.33 | n/a | 3 | Jul 15, 2025 | |
| TDOC Teladoc Health | Maintained: Hold | $8 | $8.91 | n/a | 1 | Apr 30, 2025 | |
| PRVA Privia Health Group | Maintained: Buy | $26 → $30 | $24.67 | n/a | 3 | Mar 5, 2025 | |
| MDRX Veradigm Inc. | Maintained: Hold | $13 → $7 | $5.00 | n/a | 9 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $255 → $250 | $213.22 | n/a | 3 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $280 | $194.46 | n/a | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $55 | $20.99 | n/a | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $20 | $18.67 | n/a | 5 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $5 → $3.9 | $11.48 | n/a | 8 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $3 | $0.7248 | n/a | 7 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $119.90 | n/a | 1 | Dec 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | - | n/a | 5 | May 6, 2020 |
OptimizeRx
May 13, 2026
Rated: Hold
Price Target: $10 → $7
Current: $6.38
Upside: +9.72%
Health Catalyst
May 12, 2026
Maintained: Hold
Price Target: $2 → $1.75
Current: $2.15
Upside: -18.60%
Certara
May 12, 2026
Maintained: Buy
Price Target: $12 → $9
Current: $7.75
Upside: +16.13%
Phreesia
Mar 31, 2026
Maintained: Buy
Price Target: $37 → $20
Current: $10.63
Upside: +88.15%
Definitive Healthcare
Feb 27, 2026
Maintained: Hold
Price Target: $5 → $3
Current: $0.6736
Upside: +345.37%
Evolent Health
Feb 25, 2026
Maintained: Buy
Price Target: $7
Current: $3.81
Upside: +83.73%
Simulations Plus
Jul 15, 2025
Maintained: Buy
Price Target: $28 → $20
Current: $18.33
Upside: n/a
Teladoc Health
Apr 30, 2025
Maintained: Hold
Price Target: $8
Current: $8.91
Upside: n/a
Privia Health Group
Mar 5, 2025
Maintained: Buy
Price Target: $26 → $30
Current: $24.67
Upside: n/a
Veradigm Inc.
Jan 31, 2025
Maintained: Hold
Price Target: $13 → $7
Current: $5.00
Upside: n/a
Dec 19, 2024
Initiated Coverage: Buy
Price Target: $255 → $250
Current: $213.22
Upside: n/a
Dec 19, 2024
Initiated Coverage: Buy
Price Target: $280
Current: $194.46
Upside: n/a
Dec 19, 2024
Initiated Coverage: Hold
Price Target: $55
Current: $20.99
Upside: n/a
Aug 5, 2022
Maintained: Buy
Price Target: $15 → $20
Current: $18.67
Upside: n/a
May 11, 2022
Maintained: Sell
Price Target: $5 → $3.9
Current: $11.48
Upside: n/a
May 5, 2022
Maintained: Hold
Price Target: $4 → $3
Current: $0.7248
Upside: n/a
Dec 20, 2021
Maintained: Buy
Price Target: n/a
Current: $119.90
Upside: n/a
May 6, 2020
Reiterated: Hold
Price Target: n/a
Current: -
Upside: n/a